Does chronic H. pylori infection drive systemic low-grade inflammation detectable as higher hs-CRP and increased monocytes?

Chronic Helicobacter pylori (H. pylori) infection is a recognized driver of systemic low-grade inflammation, extending its immunological impact far beyond the gastric mucosa. This systemic involvement is measurable through standard clinical biomarkers of inflammation and innate immune activation.

Clinical and effectiveness evidence

Large-scale clinical data and meta-analyses consistently link H. pylori status to elevated markers of systemic inflammation.

• High-sensitivity C-reactive protein (hs-CRP): Individuals positive for H. pylori frequently exhibit significantly higher hs-CRP levels compared to uninfected controls. hs-CRP is a precise indicator of the low-grade inflammatory state associated with chronic infections.
• Monocyte counts: Infection is associated with increased circulating monocyte levels (monocytosis). Furthermore, the Systemic Inflammation Response Index (SIRI) and Systemic Immune-Inflammation Index (SII), which incorporate monocyte and neutrophil counts, are often elevated in infected patients.
• Impact of eradication: Successful eradication therapy has been shown to result in a measurable reduction of these systemic biomarkers. Specifically, hs-CRP levels typically decline following the clearance of the bacterium, supporting a causal relationship between the infection and the systemic inflammatory profile.

Mechanistic explanations

The transition from localized gastric inflammation to systemic immune activation occurs through several key biological pathways:

• Cytokine spillover: Chronic infection activates gastric epithelial cells and resident macrophages, triggering the production of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α. These mediators "spill over" from the stomach into the general circulation, driving systemic responses.
• Innate immune activation: H. pylori virulence factors, particularly those associated with the cag pathogenicity island (CagA), activate the TLR2/MyD88/NF-κB signaling pathway and the NLRP3 inflammasome within myeloid cells. This process stimulates the production and recruitment of monocytes.
• Molecular mimicry: Some H. pylori antigens can trigger autoantibody production through molecular mimicry, further contributing to a persistent state of immune activation and linking the infection to extragastric autoimmune and cardiovascular risks.

Bottom line

Chronic H. pylori infection drives systemic low-grade inflammation and immune activation, which is reliably reflected in elevated hs-CRP and peripheral monocyte counts. These biomarkers generally normalize following successful eradication of the infection.